Duke-Coulter Translational Partnership Grant

Duke-Coulter Translational Partnership Grant

Funds clinicians and translational researchers for Duke Coulter Translational Partnership Grant in biotechnology and medical technology.

The Duke-Coulter Translational Partnership Grant is an internal annual funding programme at Duke University, supported by endowment income from the Wallace H. Coulter Foundation. Approximately $700,000 is distributed each year to three to five Duke faculty teams, with individual project awards ranging from $40,000 to $330,000. The programme targets translational biomedical engineering research addressing unmet clinical needs. Each project must be led by a co-principal investigator team pairing a faculty member with a primary or secondary appointment in Duke Biomedical Engineering with a second co-PI holding a Duke School of Medicine clinical faculty position who has access to patients or patient samples.

Awards cover one year of research costs. Indirect cost recovery is zero — the 0% F&A rate applies to all direct costs including subcontracts. Continued funding beyond year one requires re-competition; there is no automatic renewal. An Oversight Committee and Coulter Program Director govern project selection and milestone monitoring. Duke has participated in the Coulter Foundation's translational partnership model since the Phase I endowment in 2005, and the programme continues from accumulated endowment returns.

The programme is not open to external applicants. Eligibility is limited to Duke faculty meeting both the BME appointment and the School of Medicine clinical access criteria simultaneously. Specific cycle open and deadline dates are not published externally; faculty should contact the Duke BME department or Coulter Program Director for the current annual cycle schedule. The combination of no indirect costs, co-PI clinical access requirements, and annual re-competition makes this programme distinct from standard extramural grant mechanisms.